Synthetic peptide, and cosmetic composition or pharmaceutical composition and application thereof
US-2024352069-A1 · Oct 24, 2024 · US
US2016159859A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016159859-A1 |
| Application number | US-201414904715-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jul 15, 2014 |
| Priority date | Jul 15, 2013 |
| Publication date | Jun 9, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
This invention relates generally to the discovery of novel protease-resistant peptide ligands and uses thereof. Specifically, the present invention provides a protease-resistant peptide with three to twenty amino acids capable of binding a biological and comprising one or more basic amino acid(s) and I or aromatic amino acids, wherein one or more of the amino acids is substituted with a non-naturally occurring amino acid analog.
Opening claim text (preview).
What is claimed is: 1 . A protease-resistant peptide comprising three to twenty amino acids capable of binding a biological and comprising one or more basic amino acid(s) or aromatic amino acids, wherein one or more of the amino acids is substituted with a non-naturally occurring amino acid analog. 2 . The protease-resistant peptide of claim 1 , wherein the non-natural amino acid analog is listed in Table 6. 3 . The protease-resistant peptide of claim 1 wherein the peptide is a hexapeptide. 4 . The protease-resistant peptide of claim 1 , wherein the protease-resistant peptide is a hexapeptide and has the sequence HWRGWV, HYFKFD and HFRRHL (SEQ ID NOS:1-3) prior to substitution with the non-naturally occurring amino acid analog(s). 5 . The protease-resistant peptide of claim 1 , wherein the peptide is resistant to digestion by endopeptidases. 6 . The protease-resistant peptide of claim 1 , wherein the peptide is resistant to digestion by exopeptidases. 7 . The protease-resistant peptide of claim 1 , wherein the endopeptidase is alpha-chymotrypsin. 8 . The protease-resistant peptide of claim 1 , wherein the endopeptidase is trypsin. 9 . A solid support coupled to the protease-resistant peptide of claim 1 . 10 . A method of purification of a biological which comprises contacting the solid support of claim 9 with the biological under suitable conditions such that the biological binds to the solid support; washing the solid support and bound biological; and eluting the biological from the solid support so as to purify the biological. 11 . The method of claim 10 , wherein the biological is an antibody. 12 . A diagnostic kit comprising the solid support of claim 9 .
having 5 to 11 amino acids · CPC title
having 12 to 20 amino acids (gastrins C07K14/595; somatostatins C07K14/655; melanotropins C07K14/68) · CPC title
Affinity chromatography or related techniques based upon selective absorption processes · CPC title
Purification, fragmentation · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.